Insider Trading Alert - ENTA, HBI And MOFG Traded By Insiders - TheStreet

Wednesday, Nov. 25, 2015, 93 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $0.05 to $93,690,000.00.

Highlighted Stocks Traded by Insiders:

Enanta Pharmaceuticals (ENTA) - FREE Research Report

Mellett Paul J, who is Treasurer and CFO at Enanta Pharmaceuticals, sold 6,000 shares at $30.15 on Nov. 25, 2015. Following this transaction, the Treasurer and CFO owned 54,397 shares meaning that the stake was reduced by 9.93% with the 6,000-share transaction.

The shares most recently traded at $31.94, up $1.79, or 5.59% since the insider transaction. Historical insider transactions for Enanta Pharmaceuticals go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 6,000
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 21,000
  • 24-Week # shares bought: 2,400
  • 24-Week # shares sold: 43,500

The average volume for Enanta Pharmaceuticals has been 361,100 shares per day over the past 30 days. Enanta Pharmaceuticals has a market cap of $598.8 million and is part of the health care sector and drugs industry. Shares are down 37.07% year-to-date as of the close of trading on Wednesday.

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the infectious disease field in the United States. The company has a P/E ratio of 7.8. Currently, there are 2 analysts who rate Enanta Pharmaceuticals a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ENTA - FREE

TheStreet Quant Ratings

rates Enanta Pharmaceuticals as a

sell

. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself and poor profit margins. Get the full

Enanta Pharmaceuticals Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Hanesbrands (HBI) - FREE Research Report

Noll Richard A, who is Ceo at Hanesbrands, sold 200,000 shares at $31.72 on Nov. 25, 2015. Following this transaction, the Ceo owned 1.4 million shares meaning that the stake was reduced by 12.82% with the 200,000-share transaction.

The shares most recently traded at $31.43, down $0.29, or 0.93% since the insider transaction. Historical insider transactions for Hanesbrands go as follows:

  • 4-Week # shares sold: 468,652
  • 12-Week # shares sold: 468,652
  • 24-Week # shares sold: 483,652

The average volume for Hanesbrands has been 3.6 million shares per day over the past 30 days. Hanesbrands has a market cap of $12.4 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 12.99% year-to-date as of the close of trading on Wednesday.

Hanesbrands Inc., a consumer goods company, designs, manufactures, sources, and sells a range of basic apparels for men, women, and children in the United States. The company operates through four segments: Innerwear, Activewear, Direct to Consumer, and International. The stock currently has a dividend yield of 1.27%. The company has a P/E ratio of 32.2. Currently, there are 8 analysts who rate Hanesbrands a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HBI - FREE

TheStreet Quant Ratings

rates Hanesbrands as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and notable return on equity. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

Hanesbrands Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

MidWestOne Financial Group (MOFG) - FREE Research Report

Albert Larry D, who is Director at MidWestOne Financial Group, bought 7,250 shares at $29.00 on Nov. 25, 2015. Following this transaction, the Director owned 7,750 shares meaning that the stake was boosted by 1450% with the 7,250-share transaction.

The shares most recently traded at $31.99, up $2.99, or 9.35% since the insider transaction. Historical insider transactions for MidWestOne Financial Group go as follows:

  • 4-Week # shares bought: 22,250
  • 4-Week # shares sold: 4,000
  • 12-Week # shares bought: 22,250
  • 12-Week # shares sold: 4,000
  • 24-Week # shares bought: 22,250
  • 24-Week # shares sold: 4,000

The average volume for MidWestOne Financial Group has been 14,000 shares per day over the past 30 days. MidWestOne Financial Group has a market cap of $356.5 million and is part of the financial sector and banking industry. Shares are up 8.47% year-to-date as of the close of trading on Tuesday.

MidWestOne Financial Group, Inc. operates as the bank holding company for MidWestOne Bank that provides commercial and retail banking products and services. The stock currently has a dividend yield of 1.92%. The company has a P/E ratio of 14.6. Currently, there are 2 analysts who rate MidWestOne Financial Group a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MOFG - FREE

TheStreet Quant Ratings

rates MidWestOne Financial Group as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, growth in earnings per share, increase in net income and good cash flow from operations. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

MidWestOne Financial Group Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.